Statens Serum Institut

We strengthen health through disease control and research.

SSI has more than 100 years of experience in research, development and manufacturing of biologics.

The Danish Minister of Health initiates HPV catch-up programmes for boys and young men

12 February 2020

The Danish Minister of Health initiates HPV catch-up programmes for boys and young men

Read more

News

Statens Serum Institut (SSI) solves essential COVID-19 testing deficiency problem

27 March 2020
Pneumonia outbreak with novel coronavirus in China COVID-19

26 February 2020
The Danish Minister of Health initiates HPV catch-up programmes for boys and young men

12 February 2020
More Campylobacter outbreaks than expected – and more people fall ill when it rains

12 February 2020
New professor at Statens Serum Institut with focus on modes of transmission and epidemics

7 February 2020

More News

Temaer

Vaccine Research

Vaccine Research

Vaccine research at Statens Serum Institut goes back to the institute’s founding in 1902, when it was set up to produce antisera for Diphtheria. Research soon expanded to other epidemic diseases. Today the main effort is devoted to vaccines against tuberculosis, chlamydia, HIV and novel adjuvants to direct and potentiate the immune responses.

Childhood vaccination programme

Childhood vaccination programme

Vaccinations are given by the local general practitioners who also give advice to the parents. There is no fee for vaccinations given to persons under 18 years of age.

Danish National Biobank

Danish National Biobank

The Danish National Biobank stores millions of samples available for use in specific research projects.

Antibodies

SSI Antibodies develops, produces and sells monoclonal and polyclonal antibodies as well as growth media additives and MBL standards worldwide.